-
公开(公告)号：EP3395332A1
公开(公告)日：2018-10-31
申请号：EP17382230.5
申请日：2017-04-28
申请人： Chemo Research, S.L.
CPC分类号： A61K31/57 , A61K9/10 , A61K9/4858 , A61K31/565 , A61K47/44 , A61P5/30 , A61P5/34
摘要： The present invention provides novel softgel capsules of a women health care hormone, as well as to a process for the preparation thereof. In particular, the present invention relates to novel softgel capsules of a women health care hormone, which are capable of reducing allergic reactions, while maintaining an adequate solubility of the hormone in the administration thereof.
-
公开(公告)号：EP4212146A3
公开(公告)日：2023-09-27
申请号：EP23154951.0
申请日：2013-02-13
申请人： Chemo Research, S.L.
IPC分类号： A61K9/00 , A61K47/32 , A61K47/34 , A61K31/00 , A61F6/06 , A61P15/18 , A61F6/14 , A61K31/567 , A61K31/569 , A61K31/57 , A61K45/06 , A61P15/00
摘要： It relates to a device comprising (a) a core comprising polyurethane; (b) a sheath comprising ethylene vinyl acetate copolymer, said sheath substantially or completely surrounding said core; and (c) one or more active pharmaceutical ingredients dissolved or dispersed in said core and/or said sheath; and to a process for its preparation.
-
公开(公告)号：EP3030224A1
公开(公告)日：2016-06-15
申请号：EP14749773.9
申请日：2014-08-04
申请人： Chemo Research, S.L.
发明人： AMIGHI, Karim , SERENO GUERRA, Antonio , RONCHI, Celestino , WAUTHOZ, Nathalie , HERNÁNDEZ HERRERO, Gonzalo
CPC分类号： A61K9/1623 , A61K9/0075 , A61K9/1688 , A61K9/1694 , A61K31/439 , A61K31/4704 , A61K45/06 , A61K2300/00
摘要： The present invention relates to inhalable particles comprising an intimate mixture which consists of a) an amorphous tiotropium compound, b) an amorphous indacaterol compound, and c) a sugar derivative, wherein the weight of the sugar derivative is comprised from 0 to 85% relative to the weight of the inhalable particles. It also relates to a pharmaceutical composition comprising the inhalable particles of the invention, to a process for their preparation, and to their use in the treatment of asthma or chronic obstructive pulmonary disease (COPD).
-
公开(公告)号：EP4212146A2
公开(公告)日：2023-07-19
申请号：EP23154951.0
申请日：2013-02-13
申请人： Chemo Research, S.L.
IPC分类号： A61K9/00 , A61K47/32 , A61K47/34 , A61K31/00 , A61F6/06 , A61P15/18 , A61F6/14 , A61K31/567 , A61K31/569 , A61K31/57 , A61K45/06 , A61P15/00
摘要： It relates to a device comprising (a) a core comprising polyurethane; (b) a sheath comprising ethylene vinyl acetate copolymer, said sheath substantially or completely surrounding said core; and (c) one or more active pharmaceutical ingredients dissolved or dispersed in said core and/or said sheath; and to a process for its preparation.
-
-
6.发明公开FORMULATION OF AMORPHOUS CALCIUM L-5-METHYLTETRAHYDROFOLATE (L-5-MTHF-Ca) 审中-公开非结晶钙-L-5-甲基四氢叶酸的表达（L-5-MTHF-CA）
公开(公告)号：EP2976066A1
公开(公告)日：2016-01-27
申请号：EP14709708.3
申请日：2014-03-13
申请人： Chemo Research, S.L.
IPC分类号： A61K9/20 , A61K31/519
CPC分类号： A61K9/2013 , A61K9/2018 , A61K9/2054 , A61K9/2095 , A61K31/198 , A61K31/519 , A61K31/567 , A61K31/585 , A61K2300/00
摘要： The present invention relates to a dosage form which comprises amorphous calcium L-5-methylfolate and cysteine as stabilizing agent and optionally, further auxiliary agents. The dosage forms according to the invention resolves the problem of instability of amorphous calcium L-5- methylfolate to the oxidation by air.
-
公开(公告)号：EP3615009A1
公开(公告)日：2020-03-04
申请号：EP18721748.4
申请日：2018-04-27
申请人： Chemo Research, S.L.
IPC分类号： A61K9/48 , A61K31/57 , A61K31/565 , A61P5/34 , A61P5/30
-
公开(公告)号：EP3030224B1
公开(公告)日：2019-02-27
申请号：EP14749773.9
申请日：2014-08-04
申请人： Chemo Research, S.L.
发明人： AMIGHI, Karim , SERENO GUERRA, Antonio , RONCHI, Celestino , WAUTHOZ, Nathalie , HERNÁNDEZ HERRERO, Gonzalo
IPC分类号： A61K45/06 , A61K31/439 , A61K31/4704 , A61K9/00 , A61K9/16
-
公开(公告)号：EP2814458A2
公开(公告)日：2014-12-24
申请号：EP13705955.6
申请日：2013-02-13
申请人： Chemo Research, S.L.
CPC分类号： A61K9/0036 , A61F6/142 , A61K9/0002 , A61K9/0092 , A61K31/567 , A61K31/569 , A61K31/57 , A61K45/06 , A61K47/32 , A61K47/34 , A61K2300/00
摘要： It relates to a device comprising (a) a core comprising polyurethane; (b) a sheath comprising ethylene vinyl acetate copolymer, said sheath substantially or completely surrounding said core; and (c) one or more active pharmaceutical ingredients dissolved or dispersed in said core and/or said sheath; and to a process for its preparation.
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.011 秒)
